Karen J. Wilson, SVP, Finance & PAO at Jazz Pharmaceuticals plc (JAZZ), sold 11,250 shares at $167.00 ($1.9M) on 2014-02-27, disclosed to the SEC on 2014-03-03.
Open-market sale of $1.9M JAZZ by SVP, Finance & PAO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $166.20 | 3,250 | $540K | 28.8% |
| 2 | $167.00 | 8,000 | $1.3M | 71.2% |
| Total | $166.77 avg | 11,250 | $1.9M | 100% |
| Filing → |
| JAZZ | SELL | 2018-05-15 | $620K | — | Filing → |
| JAZZ | SELL | 2018-04-12 | $604K | — | Filing → |
| JAZZ | SELL | 2017-04-27 | $204K | — | Filing → |